Impact of Sustained Virologic Response with Direct‐Acting Antiviral Treatment on Mortality in Patients with Advanced Liver Disease

Hepatology ◽  
2018 ◽  
Vol 69 (2) ◽  
pp. 487-497 ◽  
Author(s):  
Lisa I. Backus ◽  
Pamela S. Belperio ◽  
Troy A. Shahoumian ◽  
Larry A. Mole
Keyword(s):  
Liver Disease ◽  
Sustained Virologic Response ◽  
Antiviral Treatment ◽  
Virologic Response ◽  
Advanced Liver Disease ◽  
Direct Acting Antiviral ◽  
Direct Acting

Direct-acting antiviral sustained virologic response: Impact on mortality in patients without advanced liver disease

Hepatology ◽  
2018 ◽  
Vol 68 (3) ◽  
pp. 827-838 ◽  
Author(s):  
Lisa I. Backus ◽  
Pamela S. Belperio ◽  
Troy A. Shahoumian ◽  
Larry A. Mole
Keyword(s):  
Liver Disease ◽  
Sustained Virologic Response ◽  
Virologic Response ◽  
Advanced Liver Disease ◽  
Direct Acting Antiviral ◽  
Direct Acting

scholarly journals Prevalence of occult HCV infections in Saudi patients who achieved sustained virologic response with direct acting antiviral treatment

2020 ◽  
Vol 5.1 (1) ◽  
pp. 7-12
Author(s):  
Hamad Al Ashgar ◽  
Mohammed Al Quaiz ◽  
Khalid Al Kahtani ◽  
Ahmed AlQahtani ◽  
Hussa Alhussaini ◽  
...  
Keyword(s):  
Sustained Virologic Response ◽  
Antiviral Treatment ◽  
Virologic Response ◽  
Direct Acting Antiviral ◽  
Direct Acting ◽  
Saudi Patients

scholarly journals Incidence and Impact of Persistent Viremia on SVR Rates in Patients Receiving Direct-Acting Antiviral Therapy

2020 ◽  
Vol 7 (12) ◽  
Author(s):  
Alicia B Carver ◽  
Autumn D Zuckerman ◽  
Joshua DeClercq ◽  
Leena Choi ◽  
Cody A Chastain
Keyword(s):  
Antiviral Therapy ◽  
Real World ◽  
Sustained Virologic Response ◽  
Response Rates ◽  
Virologic Response ◽  
Direct Acting Antiviral ◽  
Rapid Virologic Response ◽  
Persistent Viremia ◽  
Direct Acting ◽  
High Sustained Virologic Response

Abstract Rates of persistent viremia (PV) while on direct-acting antiviral therapy were low (5.7%) in a real-world cohort of 983 patients. High sustained virologic response rates were achieved both in patients with PV (92.9%) and those with rapid virologic response (96.5%), without significant differences.

DI-062 Sustained virologic response rates of new direct acting antiviral agents for HCV

2016 ◽  
Vol 23 (Suppl 1) ◽  
pp. A145.2-A146
Author(s):  
C Caballero Requejo ◽  
M Onteniente Candela ◽  
JJ Franco Miguel ◽  
M Garcia Coronel ◽  
A Trujillano Ruiz ◽  
...  
Keyword(s):  
Sustained Virologic Response ◽  
Antiviral Agents ◽  
Response Rates ◽  
Virologic Response ◽  
Direct Acting Antiviral ◽  
Direct Acting ◽  
Direct Acting Antiviral Agents
Sign in / Sign up

Export Citation Format

Share Document